Solid Biosciences Inc. is a cutting-edge biotechnology company focused on developing therapeutics for Duchenne muscular dystrophy (DMD). Their innovative gene therapy approach aims to address the root cause of the disease, offering hope to those affected. With extensive research and a strong dedication to improving patient outcomes, Solid Biosciences Inc. is at the forefront of the fight against DMD.
